Unione Europea - italiano - EMA (European Medicines Agency)

regeneron ireland designated activity company (dac) - cemiplimab - carcinoma, cellule squamose - agenti antineoplastici - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salmon pharma gmbh - dexamfetaminum - attentin 5 mg,tabletten - dexamfetamini sulfas 5 mg corresp. dexamfetaminum 3.67 mg, isomaltum 147.5 mg, crospovidonum, magnesii stearas, pro compresso. - adhs - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salmon pharma gmbh - dexamfetaminum - attentin 10 mg,tabletten - dexamfetamini sulfas 10 mg corresp. dexamfetaminum 7.34 mg, isomaltum 147.7 mg, e 172 (flavum), magnesii stearas, pro compresso. - adhs - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

salmon pharma gmbh - dexamfetaminum - attentin 20 mg,tabletten - dexamfetamini sulfas 20 mg corresp. dexamfetaminum 14.68 mg, isomaltum 137.7 mg, e 172 (rubrum), magnesii stearas, pro compresso. - adhs - synthetika

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

zentiva italia s.r.l. - alprazolam - alprazolam

Unione Europea - italiano - EMA (European Medicines Agency)

boehringer ingelheim vetmedica gmbh - ricombinante turchia herpesvirus, ceppo vhvt013-69, live - prodotti immunologici per uccelli, pollame, prodotti immunologici - embryonated eggs; chicken - per l'immunizzazione attiva dei polli:per prevenire la mortalità e ridurre i segni clinici e le lesioni infettive bursal malattia. per ridurre la mortalità, i segni clinici e le lesioni della malattia di marek.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

doc generici srl - zolpidem - zolpidem

Unione Europea - italiano - EMA (European Medicines Agency)

viatris healthcare limited - imiquimod - condylomata acuminata; keratosis; keratosis, actinic; carcinoma, basal cell - antibiotici e chemioterapici per uso dermatologico - imiquimod cream is indicated for the topical treatment of :external genital and perianal warts (condylomata acuminata) in adults. small superficial basal cell carcinomas (sbccs) in adults. clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses (aks) on the face or scalp in immunocompetent adult patients when size or number of lesions limit the efficacy and/or acceptability of cryotherapy and other topical treatment options are contraindicated or less appropriate.

Italia - italiano - Ministero della Salute

ceva salute animale s.p.a. - benazepril cloridrato - benazepril cloridrato - 2.5 milligrammo (i), benazepril cloridrato - 5 milligrammo (i), benazepril cloridrato - 5 mg, benazepril cloridrato - 2.5 mg - benazepril

Italia - italiano - Ministero della Salute

elanco gmbh - virus borsite infettiva aviaria (malattia di gumboro), ceppo v217, vivo - virus borsite infettiva aviaria (malattia di gumboro), ceppo v217, vivo - 1.5 log 10 dle50 - dose letale 50% embrioni, virus borsite infettiva aviaria (malattia di gumboro); ceppo v217; vivo - 1.5 log 10 dle50 - dose letale 50% embrioni, virus attenuato della malattia di gumboro - 10 dle-50 - avian infectious bursal disease virus (gumboro disease)